Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.


1:00

Shared 56 years ago

107 views

1:00

Shared 56 years ago

214 views

1:00

Shared 56 years ago

124 views

1:00

Shared 56 years ago

75 views

1:00

Shared 56 years ago

305 views

1:00

Shared 56 years ago

149 views

1:00

Shared 56 years ago

506 views

1:00

Shared 56 years ago

465 views